Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors. Our investment approach is global, building leading healthcare companies and groundbreaking technologies with the potential to enhance human lives. Our primary focus is direct secondary transactions, offering adaptable liquidity solutions to investors and corporations.

With a history spanning over 20 years, Rosetta has engaged in 50+ venture investments through direct secondary transactions, demonstrating extensive proficiency in executing complex transactions effectively

As secondary investors, we address the needs of investors or corporations aiming to divest part or all of their investment assets, as well as those seeking additional capital and resources to enhance their investment strategies

We inject fresh capital into companies during follow-on financings, providing crucial support during pivotal growth stages

Our seasoned team collaborates strategically with portfolio company boards, management teams, and co-investors, facilitating successful corporate partnerships, IPOs, and trade sales. Our goal is to enhance the value of our investments and contribute to the advancement of healthcare and technology

Rosetta Capital has invested in 80+ healthcare companies through inception and has achieved over 30+ M&A and IPO exits.

Rosetta Capital

Org chart

Teams

Offices